Trending...
- Keep Black Love Alive --Spelman Women's Research and Resource Center and chromatic black™ Sponsor Well-Being Advocacy Forum
- Announcing The Christina Hepburn Breast Cancer Support Campaign
- InventHelp Inventor Develops New Chemical/Mineral Treatment for Pools (LGT-193)
SAN JOSE, Calif. - nvtip -- CPC Scientific Inc., a leading global peptide CRDMO (Contract Research, Development, and Manufacturing Organization) has invested in a new peptide API (Active Pharmaceutical Ingredient) manufacturing site, bringing many new jobs to Rocklin, California. The 41,000 sq ft facility located at 3880 Atherton Rd, Rocklin, CA 95765 will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity and will diversify CPC Scientific's supply chain.
"CPC Scientific is entering an exciting period of growth and innovation for peptide and oligonucleotide therapeutic development and manufacturing, and we will continue to provide therapeutic APIs to pharmaceutical and biotech companies around the world. We are very pleased to partner with the City of Rocklin, California to bring manufacturing and Life-Science jobs to local American workers," said Shawn Lee, Ph.D., CEO.
Expanding CPC Scientific's manufacturing footprint in North America enables them to continue to produce innovative peptide products while providing additional capacity to specialty peptide APIs more rapidly.
More on nvtip.com
Peptide-based therapeutic candidates have been the fastest growing sector among all the chemical synthesized NCEs (New Chemical Entities) for new drug development in recent years. For over two decades, CPC Scientific has been a reliable partner for its clients all over the world including multinational pharmaceutical companies, biotech companies, and academic institutions by providing value-added one-stop-shop development and manufacturing services to support their clinical trials. CPC Scientific has been successfully supplying commercialized APIs to their clients in the U.S., Europe, Australia, Japan, and China for their peptide-based drugs and medical devices. By expanding their GMP manufacturing footprint, the CRDMO will enable their clients and partners to have multiple geographic options to ensure a secure API supply chain.
"We have helped many of our clients to bring an innovative drug into the market from a concept. With the new Rocklin site, we believe we will be able to contribute more especially to the Northern American market and we will continue making our efforts with our decades of peptide synthesis expertise to help our clients to save lives and improve human health worldwide," said Shawn Lee, Ph.D.
More on nvtip.com
The new Rocklin CGMP facility is scheduled to be online and fully operational by 2023. With manufacturing operations in Hangzhou (CN) and Rocklin, CA (US), these facilities will enable CPC Scientific to help meet the growing worldwide demand for peptide-based therapeutics and diagnostics.
About CPC Scientific.
Founded in 2001, CPC Scientific is a globally recognized and leading CRDMO specializing in synthetic peptide production, which is also expanding its footprint in synthetic oligonucleotides. The company works directly with leaders in the biotechnology and pharmaceutical industries to help bring life-changing therapeutics and diagnostics to market. CPC Scientific has the capability of serving customers from early drug discovery stages through clinical trials to commercial manufacturing and is proudly supplying commercial APIs to our partners all over the world. Dozens of isolated process and purification suites for peptide manufacturing enable simultaneous multi-Kg batch size projects. With an emphasis on technology, innovation, and experience, we are proud to have facilities inspected by many government agencies including U.S. Food and Drug Administration (FDA).
"CPC Scientific is entering an exciting period of growth and innovation for peptide and oligonucleotide therapeutic development and manufacturing, and we will continue to provide therapeutic APIs to pharmaceutical and biotech companies around the world. We are very pleased to partner with the City of Rocklin, California to bring manufacturing and Life-Science jobs to local American workers," said Shawn Lee, Ph.D., CEO.
Expanding CPC Scientific's manufacturing footprint in North America enables them to continue to produce innovative peptide products while providing additional capacity to specialty peptide APIs more rapidly.
More on nvtip.com
- The Data Economics Company announces partnership with Incradia to release the ReVerse franchise on Lydion-based Game Development Platform
- Completion of funding round brings Metaphysiks one step closer to embodying the Metaverse
- On Anniversary of Surfside Tragedy, New Book Coaches Residents to Identify Warning Signs
- Health Insurance Coverage For Newborns
- Hexagon announces Nexus, a platform to connect siloed engineering and unlock smart manufacturing innovation
Peptide-based therapeutic candidates have been the fastest growing sector among all the chemical synthesized NCEs (New Chemical Entities) for new drug development in recent years. For over two decades, CPC Scientific has been a reliable partner for its clients all over the world including multinational pharmaceutical companies, biotech companies, and academic institutions by providing value-added one-stop-shop development and manufacturing services to support their clinical trials. CPC Scientific has been successfully supplying commercialized APIs to their clients in the U.S., Europe, Australia, Japan, and China for their peptide-based drugs and medical devices. By expanding their GMP manufacturing footprint, the CRDMO will enable their clients and partners to have multiple geographic options to ensure a secure API supply chain.
"We have helped many of our clients to bring an innovative drug into the market from a concept. With the new Rocklin site, we believe we will be able to contribute more especially to the Northern American market and we will continue making our efforts with our decades of peptide synthesis expertise to help our clients to save lives and improve human health worldwide," said Shawn Lee, Ph.D.
More on nvtip.com
- CHASM unveils highly-respected CEO John Kawola as its first independent board member
- RENOWNED SPORTS ICONS INDUCT CUTTING EDGE TECHNOLOGY PLATFORM MORGAN BY SUN WEST MORTGAGE COMPANY INTO MORTGAGE HALL OF FAME
- IOTech announces a major new release of Edge XRT, its software platform for time-critical OT systems
- Connect Fibre Partners With Linksys and Axiros
- Bacchus Wine & Spirits Jumps To Elite 'Top 20' Position In Beverage Dynamics Top 100 Retailers for 2022
The new Rocklin CGMP facility is scheduled to be online and fully operational by 2023. With manufacturing operations in Hangzhou (CN) and Rocklin, CA (US), these facilities will enable CPC Scientific to help meet the growing worldwide demand for peptide-based therapeutics and diagnostics.
About CPC Scientific.
Founded in 2001, CPC Scientific is a globally recognized and leading CRDMO specializing in synthetic peptide production, which is also expanding its footprint in synthetic oligonucleotides. The company works directly with leaders in the biotechnology and pharmaceutical industries to help bring life-changing therapeutics and diagnostics to market. CPC Scientific has the capability of serving customers from early drug discovery stages through clinical trials to commercial manufacturing and is proudly supplying commercial APIs to our partners all over the world. Dozens of isolated process and purification suites for peptide manufacturing enable simultaneous multi-Kg batch size projects. With an emphasis on technology, innovation, and experience, we are proud to have facilities inspected by many government agencies including U.S. Food and Drug Administration (FDA).
Source: CPC Scientific Inc.
0 Comments
Latest on nvtip.com
- Nevada's International Art Fair Includes Strong Local Music
- Robinson honored again by both Rolls-Royce and The Fabricator for excellence
- PLAYSTUDIOS 'Summer of Slots' Returns With Coast-to-Coast In-Person Events Featuring Games, Giveaways, and More
- Abendroth Fortel Offers Financial Support to Develop Agricultural Products Supply Chains
- Keep Black Love Alive --Spelman Women's Research and Resource Center and chromatic black™ Sponsor Well-Being Advocacy Forum
- THine V-by-One® HS Technology Used in NVIDIA G-SYNC® Processor
- Paul Bruno's The Original Jeeps in Pictures Now Available at Amazon
- Console & Associates: The Passing of the Camp Lejeune Act Puts Justice Within Reach
- Insightin Health Unveils Predictive Analytics Solution to Help Medicare Advantage Plans Improve Member Satisfaction
- Today!Mecha Infinity And Neuto House PH Signed A Charity Partnership Contract
- Have You Recently Lost Medicaid Health Insurance?
- Oakwood Capital Completes $8.5 Million Acquisition of Apartment Complex in Valdosta, Georgia
- Rhody Rug Stands with Ukraine Creates Limited Edition Braided Rug to Support the Efforts in Ukraine
- Snell & Wilmer Las Vegas Attorney Michael S. Alires Graduates from Leadership Las Vegas
- Lux Billet Launches Stacyc Billet Foot Pegs
- Meet Mary Pitt Who Brings Real World Security, Firearms Training, State Laws, Gun Safety, Respect & Responsibility To A Diverse Group Of Clientele
- 3,000 Ukrainian Artists you can support today: an exclusive selection of 3000 artists from Ukraine
- Farm Shop MFG, LLC Launches a Comprehensive Temperature and Moisture Management System That Monitors Grain Storage Conditions
- Sidow Sobrino returns home from filming music video in Paris, France
- Auto Dealership Buy/Sell Market Starts Strong in 2022, Outpacing First Quarter 2021: Dealership Confidence Remains High Despite Looming Economic Headwinds